Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (References)


References

 1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A.
    The chronic fatigue syndrome: a comprehensive approach to its defini-
    tion and study. International Chronic Fatigue Syndrome Study Group.
    Ann Intern Med 1994; 121:953-9.
 2. Department of Health. A report of the CFS/ME Working Group. Janu-
    ary 2002.
 3. Papanicolaou DA, Amsterdam JD, Levine S, et al. Neuroendocrine as-
    pects of chronic fatigue syndrome. Neuroimmunomodulation 2004; 11:
    65-74.
 4. Komaroff AL, Buchwald D. Chronic fatigue syndrome: an update. Annu
    Rev Med 1998; 49:1-13.
 5. Devanur LD, Kerr JR. Chronic fatigue syndrome. J Clin Virol 2006; 37:
    139-50.
 6. Vernon SD, Unger ER, Dimulescu IM, Rajeevan M, Reeves WC. Utility
    of the blood for gene expression profiling and biomarker discovery in
    chronic fatigue syndrome. Dis Markers 2002; 18:193-9.
 7. Powell R, Ren J, Lewith G, Barclay W, Holgate ST, Almond J. Identifi-
    cation of novel expressed sequences, up-regulated in the leucocytes of
    chronic fatigue syndrome patients. Clin Exp Allergy 2003; 33:1450-6.
 8. Whistler T, Unger ER, Nisenbaum R, Vernon SD. Integration of gene
    expression, clinical, and epidemiologic data to characterize chronic fa- 
    tigue syndrome. J Transl Med 2003; 1:10-8.
 9. Whistler T, Jones JF, Unger ER, Vernon SD. Exercise responsive genes
    measured in peripheral blood of women with chronic fatigue syndrome
    and matched control subjects. BMC Physiol 2005; 5:5.
10. Whistler T, Taylor R, Craddock RC, Broderick G, Klimas N, Unger ER.
    Gene expression correlates of unexplained fatigue. Pharmacogenomics
    2006; 7:395-405.
11. Grans H, Nilsson M, Dahlman-Wright K, Evengard B. Reduced levels of
    oestrogen receptor beta mRNA in Swedish patients with chronic fatigue
    syndrome. J Clin Pathol 2007; 60:195-8.
12. Grans H, Nilsson P, Evengard B. Gene expression profiling in the
    chronic fatigue syndrome. J Intern Med 2005; 258:388-90.
13. Kaushik N, Fear D, Richards SC, et al. Gene expression in peripheral
    blood mononuclear cells from patients with chronic fatigue syndrome.
    J Clin Pathol 2005; 58:826-32.
14. Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan
    MS. Gene expression profile of empirically delineated classes of unex-
    plained chronic fatigue. Pharmacogenomics 2006; 7:375-86.
15. Broderick G, Craddock RC, Whistler T, Taylor R, Klimas N, Unger ER.
    Identifying illness parameters in fatiguing syndromes using classical
    projection methods. Pharmacogenomics 2006; 7:407-19.
16. Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression
    profile exploration of a large dataset on chronic fatigue syndrome. Phar-
    macogenomics 2006; 7:429-40.
17. Fostel J, Boneva R, Lloyd A. Exploration of the gene expression corre-
    lates of chronic unexplained fatigue using factor analysis. Pharmaco-
    genomics 2006; 7:441-54.
18. Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities in
    the 1994 chronic fatigue syndrome research case definition and recom-
    mendations for resolution. International Chronic Fatigue Syndrome
    Study Group. BMC Health Serv Res 2003; 3:25.
19. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue
    scale. J Psychosom Res 1993; 37:147-53.
20. Joyce E, Blumenthal S, Wessely S. Memory, attention, and executive
    function in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry
    1996; 60:495-503.
21. Zheng Z, Wu J, Sun Z. An approach to identify over-represented cis-
    elements in related sequences. Nucleic Acids Res 2003; 31:1995-2005.
22. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of mi-
    croarray data. Bioinformatics 2002; 18:207-8.
23. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and
    display of genome-wide expression patterns. Proc Natl Acad Sci U S A
    1998; 95:14863-8.
24. Kennedy G, Spence V, Underwood C, Belch JJ. Increased neutrophil
    apoptosis in chronic fatigue syndrome. J Clin Pathol 2004; 57:891-3.
25. Levine PH, Fears TR, Cummings P, Hoover RN. Cancer and a fatiguing
    illness in Northern Nevada--a causal hypothesis. Ann Epidemiol 1998;
    8:245-9.
26. Levine PH, Atherton M, Fears T, Hoover R. An approach to studies of
    cancer subsequent to clusters of chronic fatigue syndrome: use of data
    from the Nevada State Cancer Registry. Clin Infect Dis 1994; 18(Suppl
    1):S49-53.
27. Lange G, DeLuca J, Maldjian JA, Lee H, Tiersky LA, Natelson BH. Brain
    MRI abnormalities exist in a subset of patients with chronic fatigue syn-
    drome. J Neurol Sci 1999; 171:3-7.
28. Greco A, Tannock C, Brostoff J, Costa DC. Brain MR in chronic fatigue
    syndrome. AJNR Am J Neuroradiol 1997; 18:1265-9.
29. Schwartz RB, Garada BM, Komaroff AL, et al. Detection of intracranial
    abnormalities in patients with chronic fatigue syndrome: comparison of
    MR imaging and SPECT. AJR Am J Roentgenol 1994; 162:935-41.
30. Glaser R, Padgett DA, Litsky ML, et al. Stress-associated changes in the
    steady-state expression of latent Epstein-Barr virus: implications for
    chronic fatigue syndrome and cancer. Brain Behav Immun 2005; 19:91-103.
31. Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E. Epstein-
    Barr virusinduced genes: first lymphocyte-specific G protein-coupled
    peptide receptors. J Virol 2003; 67:2209-20.
32. Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T. Antibody
    responses to Epstein-Barr virus, human herpesvirus 6 and human her-
    pesvirus 7 in patients with chronic fatigue syndrome. Intervirology
    1995; 38:269-73.
33. Chia JK. The role of enterovirus in chronic fatigue syndrome. J Clin
    Pathol 2005; 58:1126-32.
34. Glynn P. NTE: one target protein for different toxic syndromes with
    distinct mechanisms? Bioessays 2003; 25:742-5.
35. Glynn P. Neural development and neurodegeneration: two faces of neu-
    ropathy target esterase. Prog Neurobiol 2000; 61:61-74.
36. Tahmaz N, Soutar A, Cherrie JW. Chronic fatigue and organophosphate
    pesticides in sheep farming: a retrospective study amongst people reporting
    to a UK pharmacovigilance scheme. Ann Occup Hyg 2003; 47:261-7.
37. Proctor SP, Heaton KJ, Heeren T, White RF. Effects of sarin and cyclo-
    sarin exposure during the 1991 Gulf War on neurobehavioral function-
    ing in US army veterans. Neurotoxicology 2006; 27:931-9.
38. Leegwater PA, Pronk JC, van der Knaap MS. Leukoencephalopathy with
    vanishing white matter: from magnetic resonance imaging pattern to
    five genes. J Child Neurol 2003; 18:639-45.
39. Chao CC, Janoff EN, Hu SX, et al. Altered cytokine release in peripheral
    blood mononuclear cell cultures from patients with the chronic fatigue
    syndrome. Cytokine 1991; 3:292-8.
40. MacDonald KL, Osterholm MT, LeDell KH, et al. A case-control study
    to assess possible triggers and cofactors in chronic fatigue syndrome.
    Am J Med 1996; 100:548-54.
41. Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C. Chronic
    fatigue syndrome: the need for subtypes. Neuropsychol Rev 2005; 15:
    29-58.
42. Janal MN, Ciccone DS, Natelson BH. Sub-typing CFS patients on the
    basis of 'minor' symptoms. Biol Psychol 2006; 73:124-31.
43. Kerr JR, Taylor-Robinson D. David Arthur John Tyrrell CBE: 19 June
    1925-2 May 2005. Biogr Mem Fellows R Soc 2007; 53:349-63.

--------
(c) 2008 University of Chicago Press
(c) 2008 The Infectious Diseases Society of America